两阶段胸肌前乳房再造:综合综述与荟萃分析
该系统综述与荟萃分析纳入48篇文献、4461例患者和3894侧乳房,评估两阶段胸肌前乳房再造。最常见并发症为血清肿(11.19%),辅助放疗与更高的感染和假体取出率相关。作者认为该术式对特定患者是可行的手术选择。
要点
- 两阶段胸肌前乳房再造纳入48篇文献、4461例患者、3894侧乳房。
- 总体至少一种并发症发生率为21.27%,血清肿最常见(11.19%)。
- 辅助放疗与更高的感染率和假体取出率相关。
核心结论
- 两阶段胸肌前乳房再造对特定患者是可行的手术选择。
- 最常见的并发症为血清肿。
- 辅助放疗与更高的感染率和假体取出率相关。
研究设计与样本
- 系统文献检索PubMed、Cochrane和Embase数据库,遵循PRISMA指南。
- 纳入标准为与已完成两阶段胸肌前乳房再造相关的临床试验或随机临床试验。
- 共纳入48篇文章进行分析,评估4461例患者和3894侧乳房。
主要发现
- 最常实施的乳房切除术类型为保留皮肤乳房切除术,其次为保留乳头乳晕复合体乳房切除术。
- 第一阶段组织扩张器平均大小为423.64 cc,最终扩张器平均填充量为349.10 cc。
- 第一与第二手术阶段之间平均时间为6.21个月,平均随访时间为17.10个月。
- 21.27%的患者经历至少一种并发症;血清肿11.19%、感染8.97%、皮瓣坏死8.48%、包膜挛缩6.74%、波纹/皱褶11.30%、扩张器或假体暴露2.38%、假体取出8.62%。
关键数值与推荐
- 总体至少一种并发症发生率21.27%。
- 血清肿发生率11.19%,感染发生率8.97%,皮瓣坏死发生率8.48%。
- 包膜挛缩发生率6.74%,波纹/皱褶发生率11.30%。
- 扩张器或假体暴露发生率2.38%,假体取出发生率8.62%。
临床怎么用
- 作者认为两阶段胸肌前乳房再造对特定患者是可行的手术选择。
- 作者报告辅助放疗与更高的感染率和假体取出率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implant-based breast reconstruction is the most used approach for breast reconstruction following mastectomy. Prosthetic breast reconstruction helps achieve optimal results with reduced operation time, offering advantages over direct-to-implant and subpectoral reconstruction in selected patients. This study aimed to provide a comprehensive overview of the two-stage prepectoral breast reconstruction. METHODS: A systematic literature search was performed, and the search was conducted across the PubMed, Cochrane, and Embase databases by adhering to the preferred reporting items for systematic reviews and meta-analysis guidelines. The inclusion criteria encompassed clinical trials or randomized clinical trials related to completed two-stage prepectoral breast reconstruction. Statistical analyses were conducted to synthesize the data and evaluate outcomes. RESULTS: A total of 48 articles were included for analysis, evaluating 4461 patients and 3894 breasts. The most commonly performed mastectomy type was skin-sparing mastectomy, followed by nipple-areola complex-sparing mastectomy. For the first surgical step, the mean tissue expander size was 423.64 cc, with a mean final expander fill of 349.10 cc. The mean time between the first and second surgery stages was 6.21 months, and the mean follow-up time was 17.10 months. A total of 21.27% of the patients experienced at least one complication. Specifically, seroma was identified in 11.19%, infection in 8.97%, skin flap necrosis in 8.48%, capsular contracture in 6.74%, rippling/wrinkling in 11.30%, expander or implant exposure in 2.38%, and implant removal in 8.62% of the patients. CONCLUSIONS: Two-stage prepectoral breast reconstruction is a viable surgical option for selected patients. The most frequent complication was seroma. Adjuvant radiotherapy was associated with a higher rate of infection and implant removal.
引用
- Di Giuli R, Cavallero MF, Ferrari C, et al. Two-stage prepectoral breast reconstruction: A comprehensive review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40168922. doi:10.1016/j.bjps.2025.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。